Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04867395 · ClinicalTrials.gov registry record · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
A NA study of Children With Medical Complexity (CMC), sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 282
- Enrollment target
- 1
- Study location
NCT04867395: Recruiting NA study of Children With Medical Complexity (CMC), sponsored by NYU Langone Health.
NCT04867395 is a NA study of Children With Medical Complexity (CMC) that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 282 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04867395, a NA study of Children With Medical Complexity (CMC), is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.
Primary Outcome
The proportion of parents making errors in comprehension of their child's discharge instructions will be assessed. The visit will consist of a structured survey. Parents will be asked open-ended questions about their child's discharge instructions for their medications, appointments , return precautions , restrictions , equipment. Parents will be encouraged to use their written instructions when answering survey questions. The total proportion of parents making comprehension errors in an individ
Conditions Studied
Interventions
- BEHAVIORAL HELPix Care Plan
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2021-07-23 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT04867395 shows while recruiting
NCT04867395 is an interventional study that assigns participants to a tested intervention. The registered 282 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Children With Medical Complexity (CMC) appearing as the primary indexed condition, and to 1 intervention - of which HELPix Care Plan is the first listed.
NCT04867395 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04867395 about?
NCT04867395 is a clinical study titled "A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity". The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge...
What is the current status of trial NCT04867395?
This trial is currently recruiting. It is a NA study. The enrollment target is 282 participants. The study started on 2021-07-23. Estimated completion is 2027-03-31.
What conditions does trial NCT04867395 study?
This clinical trial studies the following conditions: Children With Medical Complexity (CMC).
What interventions are being tested in trial NCT04867395?
The interventions under investigation include: HELPix Care Plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT04867395?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04867395 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Children With Medical Complexity (CMC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04867395's enrollment target sits among peer trials
282 379th of 2000 higher than 1,621 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT05101070 · 282 participants · Phase 1
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
- NCT06276491 · 282 participants · Phase 1
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- NCT06369298 · 282 participants · Phase 2
Study of JK07 in Patients With Chronic Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI